Allianz SE Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Allianz SE increased its stake in UnitedHealth Group by 14.2%, acquiring an additional 7,220 shares, bringing its total holdings to 58,033 shares worth about $30.4 million.
• UnitedHealth Group recently announced a quarterly dividend of $2.21 per share, an increase from the previous dividend of $2.10, representing an annualized yield of 3.7%.
• Despite a 4.9% decline in stock price, UnitedHealth Group reported earnings of $4.08 per share for the last quarter, missing analysts' expectations, with revenue of $111.62 billion.

Allianz SE raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 58,033 shares of the healthcare conglomerate's stock after buying an additional 7,220 shares during the period. UnitedHealth Group comprises approximately 0.8% of Allianz SE's holdings, making the stock its 24th largest position. Allianz SE's holdings in UnitedHealth Group were worth $30,395,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of UNH. Commonwealth Equity Services LLC boosted its holdings in UnitedHealth Group by 1.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 299,203 shares of the healthcare conglomerate's stock worth $156,707,000 after buying an additional 3,982 shares during the period. Raiffeisen Bank International AG boosted its holdings in shares of UnitedHealth Group by 7.8% during the 1st quarter. Raiffeisen Bank International AG now owns 64,813 shares of the healthcare conglomerate's stock valued at $33,449,000 after purchasing an additional 4,704 shares during the last quarter. Smithfield Trust Co boosted its holdings in shares of UnitedHealth Group by 1.0% during the 1st quarter. Smithfield Trust Co now owns 5,435 shares of the healthcare conglomerate's stock valued at $2,849,000 after purchasing an additional 53 shares during the last quarter. Argent Trust Co boosted its holdings in shares of UnitedHealth Group by 0.9% during the 1st quarter. Argent Trust Co now owns 35,124 shares of the healthcare conglomerate's stock valued at $18,396,000 after purchasing an additional 304 shares during the last quarter. Finally, L & S Advisors Inc boosted its holdings in shares of UnitedHealth Group by 1.3% during the 1st quarter. L & S Advisors Inc now owns 6,497 shares of the healthcare conglomerate's stock valued at $3,403,000 after purchasing an additional 85 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director directly owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Down 4.9%

UnitedHealth Group stock traded down $12.16 during mid-day trading on Friday, reaching $237.40. 39,874,177 shares of the company's stock were exchanged, compared to its average volume of 17,268,408. The company has a market cap of $215.36 billion, a P/E ratio of 10.29, a P/E/G ratio of 1.50 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a fifty day moving average of $296.86 and a 200-day moving average of $414.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. UnitedHealth Group's payout ratio is 38.30%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on UNH. KeyCorp decreased their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. TD Securities restated a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $373.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.